Neuberg Diagnostics, one of the top 4 Pathology laboratory chains in India, with more than 200 labs and 2000+ collection centers and having a presence in India, South Africa, UAE, and the USA has joined forces with Sehgal Path Lab in a strategic joint venture aimed at enhancing the Haemato-Oncology segment. This collaboration marks a significant milestone for both organizations as they embark on a journey to revolutionize diagnostic services in India and beyond.

Sehgal Path Lab, with its illustrious history of 44 years of diagnostic excellence has garnered acclaim for its exceptional services in the field of Haematology. The collaboration will see Sehgal Path Lab rebranded as Neuberg Sehgal Path Lab soon, aligning with Neuberg’s commitment to delivering superior diagnostic solutions.

Dr. Kunal Sehgal, a nationally acclaimed haematopathologist, will continue to lead as the Managing Director and Chief Pathologist of the joint venture. Dr. Sehgal’s expertise and leadership will be instrumental in driving the expansion of the laboratory into a Global Center of Excellence for the Haemato-Oncology segment, with a specific focus on Flow Cytometry Assays, Bone Marrow examination and developing a Myeloma Speciality Laboratory.

Speaking about the Joint venture, Dr. GSK Velu, Chairman and Managing Director, Neuberg Diagnostics said, “I am glad to have joined hands with Dr Kunal Sehgal who is a renowned haematopathologist in India. Through strategic partnerships and continuous innovation, Neuberg Diagnostics aims to deliver unparalleled diagnostic services that positively impact patient outcomes and healthcare delivery. With four entities based in Mumbai and AG Diagnostics, a Neuberg subsidiary, in Pune, Neuberg has significantly bolstered its presence in Maharashtra. This strategic consolidation reaffirms Neuberg’s leadership position in Karnataka, Gujarat, Tamil Nadu, and Madhya Pradesh, while paving the way for further growth and innovation in Maharashtra’s healthcare landscape. Neuberg remains committed to investing in Maharashtra to solidify its position as one of the top diagnostics chains in the state within the next two years”.

Speaking about the Joint venture and the lab, Dr. Kunal Sehgal, Managing Director and Chief Pathologist, Neuberg Sehgal Path Lab said, “Sehgal Path Lab was established in 1980 by Late Dr. Kulvir Sehgal as a routine Pathology and Clinical Diagnostic Laboratory and has now expanded into a referral Haematology (Blood) and Oncology (Cancer) diagnostic centre. We are delighted to partner with Neuberg Diagnostics, a global leader in diagnostics innovation. By leveraging Neuberg’s state-of-the-art technologies and Sehgal Path Lab’s trusted reputation, the partnership aims to provide patients with unparalleled access to routine and specialised tests including advanced genetic and oncology services all under one roof.  I also look forward to expanding our research and education initiatives, training programs, and collaborations with educational institutions and research organisations to fulfil my vision of developing Haematopathology as a field in the country”

In the wake of unprecedented challenges posed by the Covid-19 pandemic, Neuberg Diagnostics has remained steadfast in its commitment to innovation and expansion. Following the establishment of its own greenfield entity and a successful joint venture with Dr. Ajay Shah to establish a Center of Excellence (COE) for OncoPath with Dr. Jay Mehta, Neuberg has further strengthened its position by acquiring a majority stake in Sehgal Path Lab.